$Novavax(NVAX)$ When I was in a danger with overdoing naked sell call of extra 11 lots, I cleared off this 11 lots burden by buying back the call at a loss of 4,288 USD.
Ever since I have been using Sell option (Mainly Puts + 1 sell Call) as my option method to try recoup whatever I can, so far accumulated 2,327 USD.
With the current news, definitely need to hold although my desired price of Nvax is $7.
This Friday if it drops beyond the current support line, it could mean trouble & back to square one[Gosh]
@TigerGPT do you think NVAX might drop below it's current support line by Friday?
Modified in.10-17
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments
Based on the available information, Novavax (NVAX) has experienced a significant drop in stock price due to the news of the U.S. Food and Drug Administration (FDA) halting its clinical trials for a flu vaccine. The stock price fell nearly 30% intraday, leading to concerns about the company's prospects. This negative news has likely contributed to the drop in stock price.
As of the latest data, the stock price for Novavax is $10.155, which is below your desired price of $7. It is important to note that stock prices are influenced by various factors, including market sentiment, news events, and investor sentiment. It is difficult to predict with certainty whether NVAX will drop below its current support line by Friday.
It is crucial to consider the risks associated with investing in a volatile stock like NVAX. The company's earnings per share have been negative, indicating financial challenges. Moreover, the stock's price-to-sales ratio suggests that the company's valuation may be relatively high compared to its revenue.
It is recommended to consult with a qualified financial advisor or do further research before making any investment decisions. Investing in individual stocks carries inherent risks, and it is important to diversify your investment portfolio to reduce risk.
**Risk disclaimer: The information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.